2019
DOI: 10.1002/sscp.201900062
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a quality by design enabled robust LC method for estimation of daptomycin in pharmaceutical dosage form

Abstract: A simple and new validated liquid chromatography method with stability‐indicating potential was established for quantifying daptomycin in formulations using a quality by design approach. Analytical target profile establishment and earmarking critical analytical attributes helped to control the method performance. Further, the control strategies for critical method variables were defined as per method intent. Youden's robustness test was applied with the dual intent of defining control strategies and evaluating… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…However, there is no similar reference stability–indicating method for the corresponding dosage form testing. In a recent trend, the QbD (Ashok, Dongala, & Katakam, 2020; Katakam & Dongala, 2020a, 2020b; Katakam, Dongala, & Ettaboina, 2020; Panda, Bera, & Pradhan, 2019) approach was regulated for use in the pharmaceutical industry, with critical process parameters (CPPs) and critical quality attributes (CQAs) established for assessment of risk and design space for (method) operating conditions. A scientific way of explaining the design of experiments (DoE) approach involves performing a series of trails (usually 18) based on the fractional factorial design to evaluate the rapid and straightforward stability‐indicating UPLC method using ultraviolet detection prior to performing method validation studies.…”
Section: Introductionmentioning
confidence: 99%
“…However, there is no similar reference stability–indicating method for the corresponding dosage form testing. In a recent trend, the QbD (Ashok, Dongala, & Katakam, 2020; Katakam & Dongala, 2020a, 2020b; Katakam, Dongala, & Ettaboina, 2020; Panda, Bera, & Pradhan, 2019) approach was regulated for use in the pharmaceutical industry, with critical process parameters (CPPs) and critical quality attributes (CQAs) established for assessment of risk and design space for (method) operating conditions. A scientific way of explaining the design of experiments (DoE) approach involves performing a series of trails (usually 18) based on the fractional factorial design to evaluate the rapid and straightforward stability‐indicating UPLC method using ultraviolet detection prior to performing method validation studies.…”
Section: Introductionmentioning
confidence: 99%